Biden’s New Medicine Rules Have Pharmaceutical Companies Slow-Walking New Therapies

Pharmaceutical companies are delaying, or outright canceling, the development of new medicines following new drug rules signed into law by President Joe Biden, Bloomberg reported.

Read full story